Fidelity Group of Funds > Fidelity Select Portfolios
Select Medical Technology and Devices Portfolio
$6.33B
Avg Monthly Net Assets
$5.43B
Total Assets
$36.27M
Total Liabilities
$5.39B
Net Assets
Select Medical Technology and Devices Portfolio is a Mutual Fund in Fidelity Select Portfolios
from Fidelity Group of Funds,
based in Massachusetts,
United States of America.
The fund has one share class
and monthly net assets of $6.33B.
On July 26th, 2024 it reported 68 holdings, the largest
being BOSTON SCIENTIFIC CORP (14.5%), DANAHER CORP (13.3%) and THERMO FISHER SCIENTIFIC INC (9.3%).
Data provided by Fincoded.
Share Classes
| Name | Class/Contract ID | Ticker | Monthly Returns (2 years) |
|---|---|---|---|
| Select Medical Technology and Devices Portfolio | C000020447 | FSMEX |
Holdings
From latest NPORT-P, filed July 26th, 2024 for period ending May 31st, 2024.
Historic holdings data available from Fincoded.
| Name | Profile | Category | Country | Value $USD | # Shares | % of Fund |
|---|---|---|---|---|---|---|
| 10X GENOMICS INC | Long | Equity-common | US | $45M | 2M | 0.83 |
| 10X GENOMICS INC CL B 144A | Long | Equity-common | US | $9M | 393K | 0.16 |
| ABBOTT LABORATORIES | Long | Equity-common | US | $159M | 2M | 2.96 |
| AGILON HEALTH INC | Long | Equity-common | US | $25M | 4M | 0.47 |
| ALCON INC | Long | Equity-common | CH | $53M | 600K | 0.99 |
| ALEDADE INC SER B1 PC PP | Long | Equity-preferred | US | $7M | 175K | 0.13 |
| ALEDADE INC SER E1 PC PP | Long | Equity-preferred | US | $2M | 59K | 0.04 |
| ALIGN TECHNOLOGY INC | Long | Equity-common | US | $33M | 128K | 0.61 |
| ASIMOV INC SER B PC PP | Long | Equity-preferred | US | $4M | 98K | 0.08 |
| ATRICURE INC | Long | Equity-common | US | $27M | 1M | 0.50 |
| BIO TECHNE CORP | Long | Equity-common | US | $22M | 280K | 0.40 |
| BOSTON SCIENTIFIC CORP | Long | Equity-common | US | $783M | 10M | 14.52 |
| BRUKER CORP | Long | Equity-common | US | $81M | 1M | 1.49 |
| CARIS LIFE SCIENCES INC SER D PC PP | Long | Equity-preferred | US | $7M | 3M | 0.13 |
| CONFORMAL MEDICAL INC SER C PC PP | Long | Equity-preferred | US | $10M | 3M | 0.18 |
| CONFORMAL MEDICAL INC SER D PC PP | Long | Equity-preferred | US | $2M | 525K | 0.04 |
| DANAHER CORP | Long | Equity-common | US | $719M | 3M | 13.34 |
| DEXCOM INC | Long | Equity-common | US | $107M | 900K | 1.98 |
| DMED BIOPHARMACEUTICAL CO LTD SER C PC PP | Long | Equity-preferred | CN | $1M | 309K | 0.03 |
| DNA SCRIPT SAS PP | Long | Equity-common | FR | $121K | 1K | 0.00 |
| DNA SCRIPT SAS SER B PC PP | Long | Equity-preferred | FR | $7K | 59 | 0.00 |
| DNA SCRIPT SAS SER C PC PP | Long | Equity-preferred | FR | $10M | 28K | 0.19 |
| DNA SCRIPT SAS(SEED) PP | Long | Equity-common | FR | $464K | 5K | 0.01 |
| DOXIMITY INC | Long | Equity-common | US | $28M | 1M | 0.51 |
| EDWARDS LIFESCIENCES CORP | Long | Equity-common | US | $232M | 3M | 4.30 |
| ELEMENT BIOSCIENCES INC SER B PC PP | Long | Equity-preferred | US | $18M | 2M | 0.34 |
| ELEVATEBIO LLC SER C PC PP (ELEVATEBIO, LLC) | Long | Equity-preferred | US | $657K | 215K | 0.01 |
| EVOLENT HEALTH INC A | Long | Equity-common | US | $27M | 1M | 0.50 |
| EXACT SCIENCES CORP | Long | Equity-common | US | $79M | 2M | 1.46 |
| Fidelity Cash Central Fund (Fidelity Revere Street Trust) | Long | Short-term investment vehicle | US | $83M | 83M | 1.55 |
| Fidelity Securities Lending Cash Central Fund (Fidelity Revere Street Trust) | Long | Short-term investment vehicle | US | $33M | 33M | 0.61 |
| FREENOME HOLDINGS INC SER C PC PP (FREENOME INC) | Long | Equity-preferred | US | $12M | 2M | 0.23 |
| FREENOME HOLDINGS INC SER D PC PP (FREENOME INC) | Long | Equity-preferred | US | $8M | 1M | 0.14 |
| GALVANIZE THERAPEUTICS CONV 6% 02/28/2027 P/P | Long | Debt | US | $2M | – | 0.05 |
| GALVANIZE THERAPEUTICS SER B PC PERP PP | Long | Equity-preferred | US | $3M | 4M | 0.06 |
| GE HEALTHCARE TECHNOLOGIES INC WI | Long | Equity-common | US | $8M | 100K | 0.14 |
| GLAUKOS CORP | Long | Equity-common | US | $133M | 1M | 2.47 |
| INSCRIPTA INC SER D PC PP | Long | Equity-preferred | US | $9M | 4M | 0.17 |
| INSPIRE MEDICAL SYSTEMS INC | Long | Equity-common | US | $79M | 500K | 1.47 |
| INSULET CORP | Long | Equity-common | US | $154M | 870K | 2.86 |
| INTUITIVE SURGICAL INC | Long | Equity-common | US | $430M | 1M | 7.98 |
| IQVIA HOLDINGS INC | Long | Equity-common | US | $151M | 690K | 2.80 |
| KARDIUM INC CONV 0% PERP PP (KARDIUM INC/CA) | Long | Equity-preferred | CA | $13M | – | 0.24 |
| KARDIUM INC SRE D-6 PC PP (KARDIUM INC/CA) | Long | Equity-preferred | CA | $9M | 14M | 0.17 |
| LIFESTANCE HEALTH GROUP INC | Long | Equity-common | US | $50M | 9M | 0.93 |
| LONZA GROUP AG | Long | Equity-common | CH | $38M | 70K | 0.70 |
| MASIMO CORP | Long | Equity-common | US | $125M | 1M | 2.31 |
| NATERA INC | Long | Equity-common | US | $40M | 380K | 0.75 |
| OMADA HEALTH INC SER E PC PP | Long | Equity-preferred | US | $9M | 2M | 0.16 |
| OUTSET MEDICAL INC | Long | Equity-common | US | $12M | 3M | 0.23 |
| PENUMBRA INC | Long | Equity-common | US | $215M | 1M | 3.98 |
| PHREESIA INC | Long | Equity-common | US | $43M | 2M | 0.80 |
| PRIVIA HEALTH GROUP INC | Long | Equity-common | US | $40M | 2M | 0.73 |
| PROCEPT BIOROBOTICS CORP | Long | Equity-common | US | $64M | 970K | 1.19 |
| PROGNOMIQ INC SER B PC PP | Long | Equity-preferred | US | $6M | 3M | 0.12 |
| PROGNOMIQ INC SER C PC PP | Long | Equity-preferred | US | $2M | 752K | 0.04 |
| PROGNOMIQ SER A-5 PC PP (PROGNOMIQ INC) | Long | Equity-preferred | US | $1M | 833K | 0.03 |
| QIAGEN NV | Long | Equity-common | NL | $26M | 600K | 0.48 |
| REPLIGEN (REPLIGEN CORP) | Long | Equity-common | US | $37M | 250K | 0.69 |
| SALUDA MEDICAL INC SER D PC PP | Long | Equity-preferred | US | $14M | 2M | 0.26 |
| SALUDA MEDICAL INC WT PP | Long | Equity-common | US | $381K | 235K | 0.01 |
| SARTORIUS STEDIM BIOTECH | Long | Equity-common | FR | $25M | 128K | 0.47 |
| STRYKER CORP | Long | Equity-common | US | $341M | 1M | 6.33 |
| TANDEM DIABETES CARE INC | Long | Equity-common | US | $26M | 500K | 0.48 |
| THERMO FISHER SCIENTIFIC INC | Long | Equity-common | US | $503M | 885K | 9.33 |
| VEEVA SYS INC CL A | Long | Equity-common | US | $148M | 850K | 2.75 |
| VERICEL CORP | Long | Equity-common | US | $15M | 308K | 0.27 |
| WEST PHARMACEUTICAL SVCS INC | Long | Equity-common | US | $23M | 70K | 0.43 |
Address
Fidelity Select Portfolios
245 Summer Street
Boston
Massachusetts
02210
United States of America
Directors
OSCAR MUNOZ
ROBERT A LAWRENCE
THOMAS A KENNEDY
BETTINA DOULTON
VICKI L FULLER
VIJAY ADVANI
THOMAS P BOSTICK
PATRICIA L KAMPLING
DONALD F DONAHUE
MICHAEL E WILEY
SUSAN TOMASKY
DAVID M THOMAS
Transfer Agents
Fidelity Investments Institutional Operations Company LLC
Pricing Services
REFINITIV US HOLDINGS INC
INTERCONTINENTAL EXCHANGE INC
Custodians
CITIBANK N.A. JAKARTA BRANCH
STANDARD CHARTERED BANK (SINGAPORE) LIMITED
STANDARD BANK OF SOUTH AFRICA LIMITED
BANK HAPOALIM BM
RBC INVESTOR SERVICES TRUST
DEUTSCHE BANK AG
HSBC BANK AUSTRALIA LIMITED
HSBC BANK PLC
SKANDINAVISKA ENSKILDA BANKEN AB (PUBL) DANMARK BRANCH
HSBC BANK PLC
CITIBANK KOREA INC
BNP PARIBAS S.A. SUCCURSALE ITALIA
CITIBANK ANONIM SIRKETI
THE HONGKONG AND SHANGHAI BANKING CORPORATION LIMITED NEW ZEALAND BRANCH
BNP PARIBAS S.A. ATHENS BRANCH
BNP PARIBAS S.A.
CITIBANK N.A.- MUMBAI BRANCH
THE HONGKONG AND SHANGHAI BANKING CORPORATION LIMITED
BNP PARIBAS S.A.
STANDARD CHARTERED BANK (CHINA) LIMITED
SKANDINAVISKA ENSKILDA BANKEN AB (PUBL)
MUFG BANK LTD.
THE HONGKONG AND SHANGHAI BANKING CORPORATION LIMITED THAILAND BRANCH
DEUTSCHE BANK AG
BROWN BROTHERS HARRIMAN & CO.
CITIBANK N.A. SAO PAULO
CREDIT SUISSE (SWITZERLAND) LTD.
SKANDINAVISKA ENSKILDA BANKEN AB (PUBL) OSLO BRANCH
SOCIETE GENERALE SUCURSAL EN ESPANA
Shareholder Servicing Agents
Fidelity Investments Institutional Operations Company LLC
Admins
Fidelity Service Company
Brokers
B RILEY FINANCIAL INC
BARCLAYS PLC
CITIGROUP INC
MORGAN STANLEY
BANK OF AMERICA CORPORATION
JEFFERIES FINANCIAL GROUP INC
GOLDMAN SACHS GROUP INC (THE)
VIRTU FINANCIAL INC
JPMORGAN CHASE and CO
UBS GROUP AG